These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9784097)

  • 21. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
    Murcia M; Morreale A; Ortiz AR
    J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors.
    Steinmetzer T; Dönnecke D; Korsonewski M; Neuwirth C; Steinmetzer P; Schulze A; Saupe SM; Schweinitz A
    Bioorg Med Chem Lett; 2009 Jan; 19(1):67-73. PubMed ID: 19036586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of selective thrombin inhibitors based on the (R)-Phe-Pro-Arg sequence.
    Danilewicz JC; Abel SM; Brown AD; Fish PV; Hawkeswood E; Holland SJ; James K; McElroy AB; Overington J; Powling MJ; Rance DJ
    J Med Chem; 2002 Jun; 45(12):2432-53. PubMed ID: 12036353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives.
    Thorstensson F; Kvarnström I; Musil D; Nilsson I; Samuelsson B
    J Med Chem; 2003 Mar; 46(7):1165-79. PubMed ID: 12646027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
    Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A
    Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The methyl group of N(alpha)(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage.
    Friedrich R; Steinmetzer T; Huber R; Stürzebecher J; Bode W
    J Mol Biol; 2002 Mar; 316(4):869-74. PubMed ID: 11884127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors.
    Platte S; Korff M; Imberg L; Balicioglu I; Erbacher C; Will JM; Daniliuc CG; Karst U; Kalinin DV
    ChemMedChem; 2021 Dec; 16(24):3672-3690. PubMed ID: 34278727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrahydro-isoquinoline-based factor Xa inhibitors.
    Kucznierz R; Grams F; Leinert H; Marzenell K; Engh RA; von der Saal W
    J Med Chem; 1998 Dec; 41(25):4983-94. PubMed ID: 9836616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ecotin modulates thrombin activity through exosite-2 interactions.
    Castro HC; Monteiro RQ; Assafim M; Loureiro NI; Craik C; Zingali RB
    Int J Biochem Cell Biol; 2006; 38(11):1893-900. PubMed ID: 16843700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the role of T7 and T12 residues on the biological properties of thrombin-binding aptamer: enhancement of anticoagulant activity by a single nucleobase modification.
    Borbone N; Bucci M; Oliviero G; Morelli E; Amato J; D'Atri V; D'Errico S; Vellecco V; Cirino G; Piccialli G; Fattorusso C; Varra M; Mayol L; Persico M; Scuotto M
    J Med Chem; 2012 Dec; 55(23):10716-28. PubMed ID: 23126678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
    Shi ZH; Li NG; Tang YP; Wei-Li ; Lian-Yin ; Yang JP; Hao-Tang ; Duan JA
    Eur J Med Chem; 2012 Aug; 54():210-22. PubMed ID: 22647223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From natural to synthetic multisite thrombin inhibitors.
    Lombardi A; De Simone G; Galdiero S; Staiano N; Nastri F; Pavone V
    Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
    Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
    J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
    Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
    Radau G; Stürzebecher J
    Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological activity of non-basic compounds as factor Xa inhibitors: SAR study of S1 and aryl binding sites.
    Komoriya S; Haginoya N; Kobayashi S; Nagata T; Mochizuki A; Suzuki M; Yoshino T; Horino H; Nagahara T; Suzuki M; Isobe Y; Furugoori T
    Bioorg Med Chem; 2005 Jun; 13(12):3927-54. PubMed ID: 15911309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compounds binding to the S2-S3 pockets of thrombin.
    Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T
    J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological activity of potent and selective inhibitors of blood coagulation factor Xa.
    Willardsen JA; Dudley DA; Cody WL; Chi L; McClanahan TB; Mertz TE; Potoczak RE; Narasimhan LS; Holland DR; Rapundalo ST; Edmunds JJ
    J Med Chem; 2004 Jul; 47(16):4089-99. PubMed ID: 15267248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.